The Clinical Management and Outcome of Nail Salon Acquired Mycobacterium fortuitum Skin Infection
|
|
- Doreen Bridges
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE The Clinical Management and Outcome of Nail Salon Acquired Mycobacterium fortuitum Skin Infection Kevin L. Winthrop, 1,2 Kim Albridge, a David South, a Peggy Albrecht, 4 Marcy Abrams, 3 Michael C. Samuel, 2 Wendy Leonard, 3 Joanna Wagner, 2 and Duc J. Vugia 2 1 Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention and 2 Division of Communicable Disease Control, California Department of Health Services, Berkeley, and 3 Santa Cruz County Health Agency and 4 Santa Cruz Medical Clinic, Santa Cruz, California Nontuberculous mycobacterial infections are becoming more common. Recently, Mycobacterium fortuitum and other rapidly growing mycobacteria have been found to cause severe skin and soft-tissue infections in association with nail salon whirlpool footbaths. We recently investigated a large outbreak of M. fortuitum furunculosis among women who received pedicures at a single nail salon. To better define the clinical course of such infections, we collected clinical details from physicians who were treating outbreak patients. We constructed multivariable linear models to evaluate the effect of antibiotic treatment on disease duration. Sixty-one patients were included in the investigation. The mean disease duration was 170 days (range, days). Forty-eight persons received antibiotic therapy for a median period of 4 months (range, 1 6 months), and 13 persons were untreated. Isolates were most susceptible to ciprofloxacin and minocycline. Early administration of therapy was associated with shorter duration of disease only in persons with multiple boils ( P!.01). One untreated, healthy patient had lymphatic disease dissemination. Mycobacterium fortuitum is one of several rapidly growing mycobacteria that are ubiquitous in soil and water habitats [1 5]. These mycobacteria are known to cause cutaneous infection, typically in association with trauma or clinical procedures [6]. In 2002, however, Winthrop et al. [7] documented a large outbreak of community-acquired infection with rapidly growing mycobacteria. In this outbreak, 1115 patrons from a single Received 19 June 2003; accepted 18 August 2003; electronically published 8 December Presented in part: 40th Annual Meeting of the Infectious Diseases Society of America, Chicago, IL, 25 October 2002 (abstract 686). a Private practice, Watsonville, California. Reprints or correspondence: Dr. Kevin L. Winthrop, Div. of Tuberculosis Elimination/Field Services, Centers for Disease Control and Prevention at the California Dept. of Health Services, Rm. 608, 2151 Berkeley Way, Berkeley, CA (kow3@cdc.gov). Clinical Infectious Diseases 2004; 38:38 44 This article is in the public domain, and no copyright is claimed /2004/ nail salon contracted severe, lower-extremity M. fortuitum furunculosis from contaminated whirlpool footbaths used in the salon. Since this time, additional outbreaks and similar sporadic cases of disease have been reported [7 9], and it has become clear that whirlpool footbath associated mycobacterial infections are more widespread than was previously appreciated. Because such infections have only recently been recognized, their natural history and optimal clinical management have not yet been elucidated. To document the clinical and diagnostic features of these infections, we observed the clinical course of a subset of persons affected by the outbreak of M. fortuitum furunculosis reported by Winthrop et al. [7]. PATIENTS AND METHODS In this observational study, we followed a subset of case patients previously identified by Winthrop et al. [7] during an initial outbreak investigation conducted 38 CID 2004:38 (1 January) Winthrop et al.
2 in To enroll patients in the study, we identified clinicians who were treating at least 1 culture-confirmed case patient from the outbreak and asked them to enroll all of their outbreak case patients ( n p 62) into our study. Outbreak case patients were defined as persons who, after having receiving a pedicure at the outbreak salon during the period of April through October 2000, developed a persistent soft-tissue infection below the knee that lasted for 12 weeks and had 1 of the following features: negative results of a routine bacterial culture, no response to routine antibiotic therapy, or clinical suspicion of mycobacterial disease by the treating physician [7]. We asked physicians to complete a standardized questionnaire that gathered clinical details for each case patient. Details included medical history, treatment regimen, duration of clinically evident infection, and disease outcome. We also recorded results of culture and antibiotic susceptibility tests, as well as dermatopathological findings from examinations of skin punch biopsy tissue specimens. Disease duration was defined as the interval between the day of disease onset (reported by patients during the initial outbreak investigation) and the day of clinical resolution (reported by treating physicians). After disease resolution, physicians asked patients to immediately report any subsequent reactivation of disease. No attempt was made to modify or influence the duration or choice of treatment among physicians. Patient follow-up occurred at intervals determined by the treating physician. Patients who received 1 antibiotic (monotherapy) or 2 antibiotics concurrently (dual-agent therapy) directed against mycobacteria for 2 weeks were considered to be treated. Patients who received no antibiotic treatment, treatment with antibiotics typically not known to have in vitro activity against mycobacteria, or treatment with antibiotics with activity against mycobacteria for!2 weeks were considered to be untreated. We evaluated the independent effect of antibiotic treatment using a variable that adjusted for the elapsed time between disease onset and the initiation of treatment. With regard to this delay in therapy initiation, persons treated with antibiotics naturally clustered into 3 categories of roughly equal numbers on the basis of the following natural breakpoints in the data: those who began treatment 1 40 days, days, or 71 days after infection onset. All case patients were recommended to undergo skin punch biopsy for mycobacterial culture. Cultures of biopsy tissue specimens were either positive or negative for mycobacteria or were not performed. We attempted to control for differences in disease duration in our data that could arise because of varying levels of experience among physicians in treating these infections. To do so, we created a physician variable and categorized treating physicians as experienced or other on the basis of the number of patients they treated. Three dermatologists (i.e., experienced physicians) evaluated 30 (50%) of 61 case patients, whereas the remaining 31 case patients were evaluated by a total of 18 other physicians, most of whom were primary care physicians or infectious disease specialists. The number of boils was recorded at the time of the patient s first presentation to the treating physician. In our analysis, we explored the relationship between the number of boils and disease duration in a univariate fashion, retaining boils as a continuous variable, and then grouped the number of boils into 4 levels (1, 2 3, 3 4, and 5 boils). The only statistically important relationship between these 2 variables occurred between 1 and 2 boils. Therefore, this dichotomized variable construct (i.e., 1 and 2) was retained for further analysis in our model. All data were entered into EpiInfo 2000, version 1.1 (Centers for Disease Control and Prevention). Univariate and stratified analyses were conducted to identify relationships between disease duration and variables that could potentially influence disease duration. Comparison of means was done with analysis of variance, and comparison of continuous variables was performed with univariate linear regression. P values for univariate analysis were calculated using Student s t test. Multivariable linear models were then constructed using the Proc GenMod procedure in SAS statistical software (SAS Institute), to evaluate the independent effects of various explanatory factors on the outcome of disease duration. P values for multivariate analysis were calculated using the Wald test. RESULTS Follow-up information was available for 61 of 62 patients; 60 (98%) were female. Patient age ranged from 13 to 53 years. No persons were immunocompromised; 3 were pregnant at the time of infection. Patients had a median number of 2 boils each (range, 1 20 boils). All lesions were present below the knee in a distribution that corresponded to the area of leg exposed to water in the whirlpool footbaths used during the pedicure procedure. The clinical appearance and natural history of the lesions in this outbreak were strikingly uniform (figures 1 4). Lesions typically first presented as small papules with a spider-bite appearance. Papules underwent characteristic progression to large fluctuant boils, often with subsequent ulceration, and eventually healed with scarring. Forty-eight persons received antibiotic therapy (33 received dual-agent therapy and 15 received monotherapy). Thirteen persons were considered to be untreated; 11 received no antibiotics, and 2 were treated for!1 week. No persons required surgical resection of lesions. All treated and untreated persons eventually had resolution of disease. One initially untreated, HIV-negative person was given antibiotic therapy after lym- M. fortuitum Skin Infection CID 2004:38 (1 January) 39
3 Figure 1. Photograph of a typical boil lesion (size is specified in centimeters) 13 weeks after onset phatic dissemination of infection and the development of a large intrathigh abscess that required drainage. Samples of the abscess were obtained for culture, and culture results were positive for M. fortuitum. Persons who received antibiotics were treated for a mean duration of 4 months (range, 1 6 months). Clinicians most frequently used ciprofloxacin, doxycycline, or clarithromycin (table 1). Patients often changed drugs during the course of treatment because of side effects, cost, or other reasons. For instance, a person who was receiving monotherapy may have initially been treated with ciprofloxacin for 3 weeks, switched to doxycycline for 8 weeks, and then switched to minocycline for 10 weeks. It is notable that doxycycline or minocycline were the drugs most frequently administered to persons who received monotherapy (14 of 15 patients, including 12 who received only doxycycline or minocycline during their entire treatment course). Patients who were receiving dual-agent therapy underwent similar changes in drugs, and use of the second antibiotic was often intermittent. Ciprofloxacin was the most frequently employed drug in dual-agent therapy (31 of 33 patients), followed by clarithromycin (20 of 33 patients), and doxycycline or minocycline (17 of 33 patients). Thirty-two persons had culture-confirmed disease. Of the remaining patients, 16 did not undergo punch biopsy for culture, 3 had biopsy tissue specimens that were incorrectly processed and not cultured, and 10 had negative results of cultures of biopsy tissue specimens. Thirty isolates were identified as M. fortuitum, and 2 were rapidly growing mycobacteria that were not identified to the species level. Isolates were generally susceptible to amikacin, cefoxitin, ciprofloxacin, doxycycline, gentamicin, and minocycline and were resistant to sulfa, clarithromycin, azithromycin, and augmentin (table 2). Only 1 (3%) of the 32 positive biopsy tissue specimens had bacilli demonstrable on an acid-fast bacilli smear. Ten patients with culture-confirmed disease also had swabs of wound drainage submitted for mycobacterial culture, and 7 swab cultures were positive. Fifteen dermatopathological reports were submitted by treating physicians. Results of histopathological analysis of the lesions were variable and seemed to be consistent with the age of the lesion that was sampled by biopsy. Older lesions tended to demonstrate chronic inflammatory changes with few inflammatory cells present. More-acute lesions displayed granuloma formation, mixed inflammatory cell infiltrate, and local tissue destruction. Such inflammatory changes were often localized in or near the hair follicle. Mycobacteria were not seen in any of the specimens that underwent pathological analysis. Treated and untreated persons were similar with respect to the prevalence of culture-positive disease (50% vs. 61%, respectively) and the proportion who were receiving treatment from experienced providers (50% vs. 54%, respectively). However, treated persons had a higher number of boils than did untreated persons (mean, 4.7 vs. 2.3 boils; P p.07) and were significantly more likely to have multiple boils (OR, 3.5; 95% CI, ; P p.05). Clinical resolution and disease onset dates were both available for 56 persons (90%) for whom disease duration could be calculated. Overall, the mean disease duration was 170 days (range, days). By univariate analysis, disease duration was similar for treated and untreated groups (mean duration, 40 CID 2004:38 (1 January) Winthrop et al.
4 Figure 2. Photograph of lesion progression (size is specified in centimeters) after central drainage 14 weeks after onset 168 vs. 177 days, respectively). Persons with culture-negative disease and those for whom no culture was performed had a shorter disease duration than did those with positive culture results (mean duration, 136 vs. 198 days; P!.01). Persons treated by experienced providers had significantly shorter durations of disease (mean duration, 143 vs. 195 days; P!.01). Initiation of treatment earlier in the disease course was linearly and significantly associated with shorter mean disease duration ( P!.01). Having a single boil versus multiple lesions was also associated with a shorter mean disease duration (mean duration, 138 vs. 181 days; P p.04). Stratified analysis suggested that the effect of treatment might have differed according to the number of boils present. In persons with multiple boils ( n p 41), therapy showed a trend toward shorter disease duration, compared with untreated persons (mean duration, 173 vs. 231 days; P p.07). Among per- Figure 3. Photograph of lesion progression (size is specified in centimeters) at 17 weeks after onset M. fortuitum Skin Infection CID 2004:38 (1 January) 41
5 Figure 4. Photograph of boil resolution, with characteristic hyperpigmented macular scar, 10 months after onset sons with only a single boil, disease durations were similar in both treated and untreated groups (mean duration, 147 vs. 123 days; P p 0.50). A final, multivariable linear regression model controlling for the noted effects of culture result, physician experience, number of boils, and the interaction between the number of boils and treatment indicated that early initiation of antibiotic therapy (1 70 days after disease onset) was associated with shorter disease duration only in persons with multiple boils ( P!.01) (table 3). with antibiotic therapy in persons with a single lesion. Given that 14 of 19 patients with a solitary lesion also underwent skin punch biopsy, it might be that removal of infecting organisms during the biopsy hastened disease resolution without the aid of antibiotic therapy. Although surgical resection of lesions has been reported by other authors in the treatment of cutaneous infection caused by rapidly growing mycobacteria [8, 10], our experience indicates that oral antibiotic therapy alone may be sufficient for DISCUSSION We observed the clinical course of 61 persons with lowerextremity M. fortuitum furunculosis acquired from whirlpool footbaths at a nail salon. Of importance, we demonstrated that these infections can be treated effectively with oral antibiotic therapy and that surgical resection is not necessary. Our data suggest that persons with more extensive disease (i.e., 1 boil) who initiate antibiotic therapy early in the disease course benefit most from therapy. Although untreated infections can be selflimited in a healthy host, we found that lymphatic dissemination of infection can occur. Patients who present for evaluation early in their disease course in particular, those with multiple boils appear to be the best candidates for antibiotic therapy. Because these infections can be self-limited (at least in healthy hosts), initiation of antibiotic therapy late in the disease course might not significantly enhance immune system response to the infection. It is unclear why our analysis failed to find benefit associated Table 1. Antibiotic therapy administered to patients who were characterized as having received treatment. Antibiotic No. (%) of patients treated a (n p 48) Ciprofloxacin 34 (71) Doxycycline 22 (46) Clarithromycin 21 (44) Minocycline 12 (25) Azithromycin 7 (15) TMP-SMX 3 (6) Levofloxacin 3 (6) NOTE. The number of patients treated with each antibiotic in the table exceeds the overall number of persons treated in the study, because many persons were treated with 11 antibiotic throughout the disease course. TMP- SMX, trimethoprim-sulfamethoxazole. a See Patients and Methods for the distinction between treated and untreated patients. 42 CID 2004:38 (1 January) Winthrop et al.
6 Table 2. Results of antibiotic susceptibility testing of 29 isolates. Antibiotic Susceptible Intermediately susceptible or resistant Mode MIC, mg/ml MIC 90, mg/ml Amikacin 29 (100) 0 (0) 1 4 Ciprofloxacin 29 (100) 0 (0) Minocycline 10 (100) 0 (0).5.5 Cefoxitin 10 (91) 1 (9) Doxycyline 16 (89) 2 (11).25 2 Gentamicin 9 (82) 2 (18) 4 8 TMP-SMX 10 (61) 16 (39) Clarithromycin 4 (14) 25 (86) Azithromycin 1 (10) 9 (90) Erythromycin 1 (9) 11 (91) Augmentin 0 (0) 11 (100) NOTE. Data are no. (%) of isolates that underwent susceptibility testing, unless otherwise indicated. TMP-SMX, trimethoprim-sulfamethoxazole. treating salon-acquired infection caused by M. fortuitum. The optimal duration of antibiotic therapy is unknown. Our patients were treated for a mean duration of 4 months. Whether dual-agent therapy is more advantageous than monotherapy is also unknown. In addition to low numbers of study subjects and frequent drug switching by patients, our assessment of this question was further complicated by the fact that more than one-half of those who were treated with dual-agent therapy were, at times, being treated with clarithromycin, a drug to which most of the M. fortuitum isolates ultimately showed resistance. In such cases, those persons were probably effectively being treated with monotherapy. Clinicians could consider choosing dual-agent therapy to possibly prevent acquired drug resistance. Acquired fluoroquinolone resistance has been demonstrated previously with ciprofloxacin monotherapy for cutaneous M. fortuitum infection [11], and acquired clarithromycin resistance has been shown in the single-agent treatment of cutaneous infection caused by M. chelonae (another rapidly growing mycobacterium) [12]. Because most physicians in our study were aware of these reports, nearly all patients who were receiving monotherapy were treated with doxycycline or minocycline throughout all or most of the treatment course. The diagnosis of such infections can be challenging without clinical suspicion of mycobacterial etiology. Although M. fortuitum and related organisms will grow on standard blood agar culture media, they typically do so only after 3 7 days under ideal conditions [6, 13]. Therefore, cultures for routine organisms frequently fail to yield these mycobacteria, because they are typically not held long enough to demonstrate such growth. Mycobacteria may also be difficult to collect for culture, particularly if swab samples of wounds are used. Other authors have recommended the use of skin punch biopsies to capture organisms for culture, and we indeed found this procedure to be more sensitive than using swab samples of wounds [14]. Finally, acid-fast bacilli smears appear to have little utility for diagnosis, because only 1 person in our cohort had bacilli demonstrable on smear. Because our study was observational by design, our ability to draw firm conclusions regarding the utility of antibiotic therapy was limited. To determine disease duration, we relied on the subjective opinion of many different physicians. It is possible that the subjective assessment of disease resolution or patient follow-up frequencies may have varied between physicians, depending on disease severity, treatment group, or some other variables associated with clinical expertise or training. We attempted to control for this by including a physician variable in our model. We were also limited in our ability to assess outcomes other than disease duration. Although all lesions were noted to result in scarring, we could not assess whether antibiotics mitigated this outcome. In summary, clinicians should consider rapidly growing mycobacteria in the differential diagnosis of any difficult-to-treat soft-tissue infection, particularly when the infection is associated with whirlpool footbaths commonly used in nail salons. Of importance, we have demonstrated that M. fortuitum furunculosis can be treated successfully with oral antibiotic therapy in otherwise healthy persons and that surgical therapy is not necessary. Our experience suggests that persons in particular, those with multifocal disease benefit most from treatment initiated early in the disease course. Although untreated infection may be self-limited, dissemination of these infections can occur among healthy individuals, and persons who are untreated should be observed closely for such complications. The risk of disease reactivation is unknown, but, at the time of writing, no persons in this study have reported recurrence of disease. Acknowledgments We thank Dr. Genevieve Ashcom, Dr. James Beckett, Dr. Lorena Bischoff, Dr. Andrew Calciano, Dr. Mitra Choudri, Dr. Table 3. Disease duration, by treatment group, in persons with multiple boils at presentation to the treating physician. Treatment group, days a No. of patients Disease duration, mean days (range) None ( ) Reference group (45 317)! ( )! ( ).44 a Interval between disease onset and initiation of treatment. b By multivariate modeling. P b M. fortuitum Skin Infection CID 2004:38 (1 January) 43
7 Leslie Christie, Dr. Thomas Deetz, Dr. Barbara Drucker, Dr. Steven Ellis, Dr. Charles Fishman, Dr. Melvin Gorlick, Dr. Leonard Moore, Dr. Daryl Nounnan, Dr. William Richards, Dr. Vaal Rothman, Dr. Molly Shields, and Dr. Michelle Violich, for their collaboration in this study; and Dr. Andrea Winquist (Centers for Disease Control and Prevention; Atlanta, GA), for her assistance. References 1. Collins CH, Grange JM, Yates MD. A review: mycobacteria in water. J Appl Bacteriol 1984; 57: Fischeder R, Schulze-Robbecke R, Weber A. Occurrence of mycobacteria in drinking water samples. Zentralbl Hyg Umwelmed 1991; 192: Covert TC, Rodgers MR, Reyes AL, Stelma GN Jr. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 1999; 65: Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97: Jones RJ, Jenkins DE. Mycobacteria isolated from soil. Can J Microbiol 1965; 11: Brown BA, Wallace RJ Jr. Infection due to nontuberculous mycobacteria. In: Mandell GL, Bennett JE, Dolan R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia, PA: Churchill Livingstone, 2000: Winthrop KL, Abrams M, Yakrus M, et al. An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 2002; 346: Sniezak PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterial infections after pedicures. Arch Dermatol 2003; 139: Arizona Department of Health Services. Mycobacterium fortuitum furunculosis associated with salon footbaths. Prevention Bulletin 2001; 15: Rappaport W, Dunington G, Norton L, Ladin D, Peterson E, Ballard J. The surgical management of atypical mycobacterial soft-tissue infections. Surgery 1990; 108: Wallace RJ Jr, Bedsole G, Sumter G. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990; 34: Wallace RJ Jr, Tanner D, Brennan PJ, Broan BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993; 119: Wallace RJ Jr. The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. Clin Chest Med 1989; 10: Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5: CID 2004:38 (1 January) Winthrop et al.
Mycobacterium fortuitum,
2009 177 Mycobacterium fortuitum 1 1) 2) 3) 1) 1) 4) 4) 5) 2) 1) 1) 2) 3) 4) 5) 21 3 16 21 7 1 Mycobacterium fortuitum 1 39 BHI 2 Ziehl Neelsen M. fortuitum MIC CPFX 0.2 mg/ml, MINO 0.78 mg/ml, CAM 100
Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections
Operational Guidance for Position Statement 17 ID 07: Standardized Case Definition for Extrapulmonary Nontuberculous Mycobacteria Infections Submission Date: April 28, 2017 Committee: Infectious Disease
6. Gonococcal antimicrobial susceptibility
6. Gonococcal antimicrobial susceptibility Key points Gonococcal AMR continues to increase worldwide and could lead to a pandemic of extensively drug-resistant (XDR) N. gonorrhoeae with serious public
Shannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center. Property of Presenter. Not for Reproduction
Shannon Kasperbauer, M.D. National Jewish Health University of Colorado Health Sciences Center Consultant: Johnson and Johnson Speaker/consultant: Insmed Examine characteristics of the RGM Define the main
HIDDEN IN PLAIN SITE:
HIDDEN IN PLAIN SITE: MYCOBACTERIUM ON THE ROUTINE BENCH Christina Partington MT(ASCP) ACL Laboratory 1 Introduction The importance of the possibility of AFB appearing in a routine culture. How to recognize
The authors assessed drug susceptibility patterns
Drug Resistance Among Tuberculosis Patients, 1991 and 1992 New York City, CYNTHIA R. DRIVER, RN, MPH THOMAS R. FRIEDEN, MD, MPH ALAN B. BLOCH, MD, MPH IDA M. ONORATO, MD All the authors are with the Division
Peritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum
Case Reports Peritoneal dialysis associated peritonitis secondary to Mycobacterium fortuitum Paula McKenzie MD, David Sotello MD, Kunal Parekh MD, Kristen Fuhrmann PharmD, Richard Winn MD Abstract We report
Nontuberculous Mycobacteria
Nontuberculous Mycobacteria Epidemiology and Clinical Management Kevin L. Winthrop, MD, MPH Associate Professor, Divisions of Infectious Diseases, Public Health and Preventive Medicine Oregon Health &
Mycobacteriosisok. Somoskövi Ákos
Mycobacteriosisok Somoskövi Ákos Phylogenetic position of the MTBC and NTM within the genus Mycobacteria Gutierrez and Somoskovi 2014 Encyclopedia of Human Biology Increased identification of NTMs Plethora
Refractory Hand Ulceration: A Case of Chronic Ulceration and Sporotrichoid Spread in a Fish Tank Hobbyist following Mycobacterium marinum Infection
137 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
Chancroid Table of Contents
Subsection: Chancroid Page 1 of 8 Chancroid Table of Contents Chancroid Fact Sheet Subsection: Chancroid Page 2 of 8 Chancroid (Haemophilus ducreyi) Overview (1,2) For a more complete description of chancroid,
Antimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
Clinical and Pathologic Features of Mycobacterium fortuitum Infections. An Emerging Pathogen in Patients With AIDS
Microbiology and Infectious Disease/ MYCOBACTERIUM FORTUITUM INFECTION IN PATIENTS WITH AIDS Clinical and Pathologic Features of Mycobacterium fortuitum Infections An Emerging Pathogen in Patients With
Appendix C. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix C Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
(Mycobacterium abscessus)
241 (Mycobacterium abscessus) 1 1 1 1,2 1,3 1,4 5 1 2 3 4 5 (Non-tuberculous mycobacterium, NTM) NTM Mycobacterium abscessus PFGE 16 (1) NTM Mycobacterium chelonae 270 CFU/ml (2) 15 NTM 0% 500 CFU/g 200
العصوي الوعاي ي الورام = angiomatosis Bacillary
1 / 7 BACILLARY ANGIOMATOSIS Epidemiology BA is most commonly seen in patients with acquired immunodeficiency syndrome (AIDS) and a CD4 count less than 50 cells/mm 3, with an incidence of 1.2 cases per
Azithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature
ISPUB.COM The Internet Journal of Dermatology Volume 7 Number 1 Azithromycin Therapy for Multiple Eruptive Milia: A Report of a Case, New Treatment Option, and Review of the Literature E McCarley O'Shea,
Weekly. August 8, 2003 / 52(31);
Weekly August 8, 2003 / 52(31);735-739 Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis
Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis.
Title: Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Principal Investigator: Dick Menzies, MD Evidence base for treatment of INH resistant
Title: Expanding Wound Botulism Surveillance Case Definitions
10-ID-03 Committee: Infectious Disease Title: Epanding Wound Botulism Surveillance Case Definitions I. Statement of the Problem: CSTE position statement 07-EC-02 recognized the need to develop an official
Communicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual Definitions Page 1 2.0 DEFINITIONS Many of the definitions that follow are taken from
Carbapenem Susceptibility Patterns for Clinical Isolates of Mycobacterium abscessus by
JCM Accepts, published online ahead of print on 16 December 2009 J. Clin. Microbiol. doi:10.1128/jcm.01930-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All
Rochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH)
Rochester Patient Safety C. difficile Prevention Collaborative: Long Term Care Antimicrobial Stewardship (funded by NYSDOH) Clinical Practice Guideline* for the Diagnosis and Management of Acute Bacterial
Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
TB Intensive San Antonio, Texas August 7-10, 2012
TB Intensive San Antonio, Texas August 7-10, 2012 Nontuberculosis Mycobacterial Lung Disease David Griffith, MD August 8, 2012 David Griffith, MD has the following disclosures to make: No conflict of interests
Cardiovascular Center Grand Rounds. December 15, 2016
Cardiovascular Center Grand Rounds December 15, 2016 Agenda Overview of Heater-Cooler Device Issue NTM Infection Incidence Chronology of Events and Communications Risk Management Implications Q&A NTM Grand
Buruli ulcer disease. Epidemiology and transmission l Clinical manifestations and diagnosis l Treatment. Chapter 2
Epidemiology and transmission l Clinical manifestations and diagnosis l Treatment Chapter 2 KEY POINTS Buruli ulcer is an infection caused by an organism called Mycobacterium ulcerans that lives in the
Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases
Diagnosis and Treatment of Nontuberculous Mycobacterial Pulmonary Diseases Jae Joon Yim, M.D. Sung Koo Han, M.D. Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Seoul National
Nontuberculous Mycobacterial Lung Disease
Non-TB Mycobacterial Disease Jeffrey P. Kanne, MD Nontuberculous Mycobacterial Lung Disease Jeffrey P. Kanne, M.D. Consultant Disclosures Perceptive Informatics Royalties (book author) Amirsys, Inc. Wolters
An Intramuscular Heroin Abuser with an Uncommon Cause of Renal Failure. Dr Wong Yuk, Dr A Tang Renal Unit, UCH
An Intramuscular Heroin Abuser with an Uncommon Cause of Renal Failure Dr Wong Yuk, Dr A Tang Renal Unit, UCH Case History Mr Chan, 58/M Chronic smoker, social drinker Work as a driver Good past health
Methicillin-Resistant Staphylococcus aureus (MRSA) S urveillance Report 2008 Background Methods
Methicillin-Resistant Staphylococcus aureus (MRSA) Surveillance Report 2008 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services
Abscess. A abscess is a localized collection of pus in the skin and may occur on any skin surface and be formed in any part of body.
Abscess A abscess is a localized collection of pus in the skin and may occur on any skin surface and be formed in any part of body. Ethyology Bacteria causing cutaneous abscesses are typically indigenous
WSLH Testing and Surveillance Updates
WSLH Testing and Surveillance Updates Wisconsin Mycobacteriology Laboratory Network annual conference November 4, 2015, Madison, WI Updates Outline Collection and Transport Smear and Culture Nucleic Acid
NTM Lecture Series. Challenging Cases: Part 1. Property of Presenter
NTM Lecture Series Challenging Cases: Part 1 Dr. Wendi Kay Drummond DO, MPH Assistant Professor of Medicine Division of Mycobacterial and Infectious Diseases Department of Medicine September 27, 2018 Disclosures
Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus
983 Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency Virus David E. Griffith, Barbara A. Brown, From the Departments
Urinary TB diagnostics in HIV
Urinary TB diagnostics in HIV SAMRC UCT Eastern Cape collaborative research symposium 20 th October 2017 David Stead Prospective PM study in Zambian tertiary hospital - All medical deaths over 1 year -
Nontuberculous Mycobacteria and Heater-Cooler Devices: A CDC Update
National Center for Emerging and Zoonotic Infectious Diseases Nontuberculous Mycobacteria and Heater-Cooler Devices: A CDC Update Kiran Perkins, MD, MPH Medical Officer Division of Healthcare Quality Promotion
Mycobacterium Marinum Skin Infection
Bahrain Medical Bulletin, Vol. 37, No. 2, June 2015 Mycobacterium Marinum Skin Infection Ahmed Anwar Aljowder, Bsc, MD* Azad Kareem Kassim, FRCPI, FRCP (Glasg), FAAD** Mazen Raees, MB, BCh, BAO, LRCP &
Mycobacterial Infections in HIV. H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine
Mycobacterial Infections in HIV H. Gene Stringer, Jr., MD Infectious Diseases Section Department of Medicine Morehouse School of Medicine Learning Objectives List the most common mycobacterial infections
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics
Global Perspective on Transmission: Value in Genotype Mapping of Disease Transmission Dynamics Neel R. Gandhi, MD Emory Rollins School of Public Health January 17, 2013 Medical Research Council BMJ 1948
Laboratory Reporting of Tuberculosis Test Results and Patient Treatment Initiation in California
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2004, p. 4209 4213 Vol. 42, No. 9 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.9.4209 4213.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
Title: Cefoxitin Continuous Infusion for Lung Infection Caused by M. abscessus group
AAC Accepts, published online ahead of print on 14 April 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.02763-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 Title: Cefoxitin
MULTIDRUG- RESISTANT TUBERCULOSIS. Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic
MULTIDRUG- RESISTANT TUBERCULOSIS Dean Tsukayama Hennepin County Medical Center Hennepin County Public Health Clinic I have no relevant financial relationships. Discussion includes off label use of: amikacin
Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review
Showa Univ J Med Sci 28 4, 373 377, December 2016 Case Report Clarithromycin-resistant Mycobacterium Shinjukuense Lung Disease: Case Report and Literature Review Makoto HAYASHI 1, Satoshi MATSUKURA 1,
DOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : NONTUBERCULOUS MYCOBACTERIA NTM PDF EBOOK EPUB MOBI Page 1 Page 2 nontuberculous mycobacteria ntm nontuberculous mycobacteria ntm pdf nontuberculous mycobacteria ntm patients and those
Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)
Appendix B Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997) Since publication of the Recommendations for Counting Reported Tuberculosis Cases 1 in January 1977, numerous changes
Treatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
Catheter-related Mycobacterium abscessus bacteremia manifested with skin nodules, pneumonia, and mediastinal lymphadenopathy
Kaohsiung Journal of Medical Sciences (2013) 29, 50e54 Available online at www.sciencedirect.com journal homepage: http://www.kjms-online.com CASE REPORT Catheter-related Mycobacterium abscessus bacteremia
Alberta Health and Wellness Public Health Disease Under Surveillance Management Guidelines March 2011
March 2011 Histoplasmosis Case Definition Confirmed Case Clinical illness [1] with laboratory confirmation of infection: Isolation of Histoplasma capsulatum from an appropriate clinical specimen (tissue
Tuberculosis in Chicago 2007
City of Chicago Communicable Disease Information Department of Public Health Richard M. Daley, Mayor May 2008 Terry Mason, MD, FACS, Commissioner www.cityofchicago.org/health/ West Side Center For Disease
A retrospective review of cases of Mycobacterium haemophilum
A retrospective review of cases of Mycobacterium haemophilum infection in Western Australia. ABSTRACT BACKGROUND: Mycobacterium haemophilum is an emerging mycobacterial pathogen causing a wide spectrum
In vitro assessment of dual drug combinations to inhibit growth of Neisseria gonorrhoeae
AAC Accepted Manuscript Posted Online 26 January 2015 Antimicrob. Agents Chemother. doi:10.1128/aac.04127-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 In vitro assessment
Title/Description: Outbreak Investigation Guidelines Department: All Departments. Effective Date: 4/97 REVISED: 1/00, 5/08 I.
Title/Description: Outbreak Investigation Guidelines Department: All Departments Personnel: All Personnel Effective Date: 4/97 REVISED: 1/00, 5/08 I. PURPOSE At Springhill Medical Center (SMC) an outbreak
Implication of species change of Nontuberculous Mycobacteria during or after treatment
Lee et al. BMC Pulmonary Medicine (2017) 17:213 DOI 10.1186/s12890-017-0539-7 RESEARCH ARTICLE Open Access Implication of species change of Nontuberculous Mycobacteria during or after Jong Sik Lee 1, Jong
HIDRADENITIS SUPPURATIVA
Print Close Window Note: Large images and tables on this page may necessitate printing in landscape mode. Copyright 2004-2005 The McGraw-Hill Companies. All rights reserved. Fitzpatrick Color Atlas, 5e
2018 Vindico Medical Education. Non-tuberculous Mycobacteria: Circumventing Difficulties in Diagnosis and Treatment
Activity presentations are considered intellectual property. These slides may not be published or posted online without permission from Vindico Medical Education (cme@vindicocme.com). Please be respectful
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
MAJOR ARTICLE Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease David E. Griffith, 1,3 Barbara A. Brown, 2 William M. Girard, 1 Bryan E. Griffith, 2 Leslie A. Couch,
JCM Accepts, published online ahead of print on 19 May 2010 J. Clin. Microbiol. doi: /jcm
JCM Accepts, published online ahead of print on 19 May 2010 J. Clin. Microbiol. doi:10.1128/jcm.00814-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS
COHORT STUDY OF HIV POSITIVE AND HIV NEGATIVE TUBERCULOSIS in PENANG HOSPITAL: COMPARISON OF CLINICAL MANIFESTATIONS Ong CK 1, Tan WC 2, Leong KN 2, Abdul Razak M 1, Chow TS 2 1 Respiratory Unit, Penang
Bilateral multiple choroidal granulomas and systemic vasculitis as presenting features of tuberculosis in an immunocompetent patient
Kumar et al. Journal of Ophthalmic Inflammation and Infection (2016) 6:40 DOI 10.1186/s12348-016-0109-9 Journal of Ophthalmic Inflammation and Infection BRIEF REPORT Open Access Bilateral multiple choroidal
Supplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Günther G, Lange C, Alexandru S, et al. Treatment outcomes
SHIGA TOXIN-PRODUCING SHIGELLA SONNEI IN SOUTHERN CALIFORNIA, 2014
SHIGA TOXIN-PRODUCING SHIGELLA SONNEI IN SOUTHERN CALIFORNIA, 2014 InFORM Conference November 20, 2015 Jennifer Nelson, MPH County of San Diego Health and Human Services Agency BACKGROUND Shiga toxins
Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis
Molecular Epidemiology of Tuberculosis Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis Overview TB transmission and pathogenesis Genotyping methods Genotyping for clinical management
An Outbreak of Mycobacterium chelonae Infection Following Liposuction
MAJOR ARTICLE An Outbreak of Mycobacterium chelonae Infection Following Liposuction Hildy Meyers, 1 Barbara A. Brown-Elliott, 2 Douglas Moore, 1 Jan Curry, 1 Cecile Truong, 1 Yansheng Zhang, 2 and Richard
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California
CDPH - CTCA Joint Guidelines Guideline for Micobacteriology Services In California These guidelines are intended to be used as an educational aid to help clinicians make informed decisions about patient
TB Intensive Houston, Texas October 15-17, 2013
TB Intensive Houston, Texas October 15-17, 2013 Nontuberculous Mycobacterial Lung Disease David Griffith, MD October 15, 2013 David Griffith, MD has the following disclosures to make: No conflict of interests
NTM Mycobacterium avium Mycobacterium intracellulare Complex
2006 67 NTM Mycobacterium aviummycobacterium intracellulare Complex 1) 1) 1) 1) 2) 1) 2) 17 8 29 18 2 9 Mycobacterium avium Mycobacterium intracellulare 6 MIC NTM MIC 1 3 NTM 5 MIC MIC M. avium 1 M. intracellulare
The treatment of patients with initial isoniazid resistance
The treatment of patients with initial isoniazid resistance 2011 INTERTB Meeting, St George s, London Patrick Phillips, MRC Clinical Trials Unit DA Mitchison, AJ Nunn. 21 st October 2011 Outline Background
Wound culture. (Sampling methods) M. Rostami MSn.ICP Rajaei Heart Center
Wound culture (Sampling methods) M. Rostami MSn.ICP Rajaei Heart Center Infection is a major impairment in delayed and nonhealing chronic wounds. Cultures of chronic wounds are not routinely performed
ICM VI-09 DEFINITION REFERENCES
TITLE/DESCRIPTION: MANAGEMENT OF SELECTED AIRBORNE AND DROPLET INFECTIOUS DISEASE EXPOSURES IN HEALTHCARE WORKERS INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All
Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018
Summary of Key Points WHO Position Paper on BCG Vaccine, February 2018 1 Introduction This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine and the 2007 WHO
Mycobacterium marinum Remains an Unrecognized Cause of Indolent Skin Infections
CASE REPORT Mycobacterium marinum Remains an Unrecognized Cause of Indolent Skin Infections Julie Steinbrink, MD; Molara Alexis, MD; Daniella Angulo-Thompson, MD; Mayur Ramesh, MD; George Alangaden, MD;
Sexually Transmitted Infection Treatment and HIV Prevention
Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.
ACCME/Disclosures. Two Patients and a Caveat 4/13/2016. Patient #1: 13 y/o boy with IPEX syndrome; s/p BMT
Two Patients and a Caveat The Use and Misuse of Molecular Methods in Mycobacterial Infections Gary W. Procop, MD Director, Molecular Microbiology Infectious Disease Pathologist Cleveland Clinic ACCME/Disclosures
Clinical review of pulmonary disease caused by Mycobacterium xenopi
Thorax 1983;38: 373-377 Clinical review of pulmonary disease caused by Mycobacterium xenopi MJ SMITH, KM CITRON From the Cardiothoracic Institute, Brompton Hospital, London ABSTRACT Mycobacterium xenopi
BCG OSTEITIS. B. Varbanova 1, V. Vasileva 1, P. Minchev 2, R. Nedeva 1 and E. Dyankov 1 BCG. . Bacille-Calmette Guerin (BCG) BCG.
68 BCG. 1,. 1,. 2,. 1. 1 1 2, BCG OSTEITIS B. Varbanova 1, V. Vasileva 1, P. Minchev 2, R. Nedeva 1 and E. Dyankov 1 1 University Hospital Sv. Marina Varna 2 University Children s Clinic of Pulmonary Diseases,
Medical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia
Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive
Received 6 October 1995/Returned for modification 27 November 1995/Accepted 29 January 1996
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1996, p. 874 878 Vol. 40, No. 4 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Activities of the Glycylcyclines N,N-Dimethylglycylamido-Minocycline
Giardiasis. Table of Contents
Table of Contents Case Definition... Error! Bookmark not defined. Reporting Requirements... 2 Etiology... Error! Bookmark not defined. Clinical Presentation... Error! Bookmark not defined. Diagnosis...
Case Report A Mysterious Gram-Positive Rods
Volume 2012, Article ID 841834, 4 pages doi:10.1155/2012/841834 Case Report A Mysterious Gram-Positive Rods Javzandulam Natsag, Zaw Min, Yasir Hamad, Bassel Alkhalil, Atiq Rahman, and Richard Williams
Management of Gonorrhea in Adolescents and Adults in the United States
SUPPLEMENT ARTICLE Management of Gonorrhea in Adolescents and Adults in the United States Sarah Kidd 1 and Kimberly A. Workowski 1,2 1 Division of STD Prevention, Centers for Disease Control and Prevention,
Clinical Decision making in Infectious Keratitis
Clinical Decision making in Infectious Stephen D. McLeod, MD Theresa M. and Wayne M. Caygill, MD Distinguished Professor and Chair Department of Ophthalmology Francis I. Proctor Foundation University of
General Infectious Diseases
Contents General Infectious Diseases Atibordee Meesing, MD Division of infectious disease Department of Medicine Khon kaen University Tuberculosis (TB) Overview of Nontuberculous Mycobacterial (NTM) Infections
Egyptian Dermatology Online Journal Vol. 5 No 2:16, December Squamous Cell Carcinoma Arising on Extensive and Chronic Lupus Vulgaris
Squamous Cell Carcinoma Arising on Extensive and Chronic Lupus Vulgaris Pathak D.* and Thapa A** Egyptian Dermatology Online Journal 5 (2): 16 * Consultant Dermatologist, Delhi Dermatology Group Kubba,
NCCID RAPID REVIEW. 1. What are the case definitions and guidelines for surveillance and reporting purposes?
NCCID RAPID REVIEW 1. What are the case definitions and guidelines for surveillance and reporting purposes? Middle East Respiratory Syndrome Coronavirus: Ten Questions and Answers for Canadian Public Health
Molecular Epidemiology of Extrapulmonary Tuberculosis
Molecular Epidemiology of Extrapulmonary Tuberculosis A Maryland State Review Jessie Torgersen PHASE Intern Maryland State Department of Health and Mental Hygiene Division of TB Control May 12, 2004 Outline
Gonorrhea, Chlamydia, and Syphilis in Alaska
Department of Health and Social Services Division of Public Health Section of Epidemiology Karen Perdue, Commissioner Karen Pearson, Director John Middaugh, MD, Editor 361 C Street, Suite 54, P.O. Box
Background & objectives
Indian J Med Res 123, February 2006, pp 119-124 Influence of sex, age & nontuberculous infection at intake on the efficacy of BCG: re-analysis of 15-year data from a double-blind randomized control trial
Management of Drug-resistant Tuberculosis (DR-TB)
Management of Drug-resistant Tuberculosis (DR-TB) Nitipatana Chierakul Division of Respiratory Disease & Tuberculosis Department of Medicine Faculty of Medicine Siriraj Hospital October 14 th, 2008 Tropical
Annual Tuberculosis Report Oregon 2007
Annual Tuberculosis Report Oregon 7 Oregon Department of Human Services Public Health Division TB Program April 8 Page 2 Table of Contents Charts Chart 1 TB Incidence in the US and Oregon, 1985-7.. page
RESEARCH NOTE. 86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006
86 Clinical Microbiology and Infection, Volume 12 Number 1, January 2006 REFERENCES 1. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179 1181. 2. Barenfanger J, Drake
Wounds and Infections: Wound Management From the ID Physician Standpoint. Alena Klochko, MD Orlando VA Medical Center Infectious Disease Department
Wounds and Infections: Wound Management From the ID Physician Standpoint Alena Klochko, MD Orlando VA Medical Center Infectious Disease Department Objectives Distinguish between colonization, critical
Pertussis Testing and Treatment Guidelines
Chicago Department of Public Health City of Chicago Rahm Emanuel, Mayor Pertussis Testing and Treatment Guidelines Date: August 1, 2012 To: Immunization Program Chicago Department of Public Health Bechara
Study design: The study was a multicentre, prospective, randomised, doubleblind, parallel-group study.
2 11 September 1.997 Page 9 of161 SYNOPSIS FUT 9403 INT : FUCIDIN VERSUS ERYTHROMYCIN IN SKIN AND SOFT TISSUE INFECTION. A comparison of sodium fusidate tablets 250mg bd (Fucidin tablets) and erythromycin
Overview of Coccidioidomycosis (Valley Fever) Stephen Munday, MD MPH Imperial County Public Health May 21, 2013
Overview of Coccidioidomycosis (Valley Fever) Stephen Munday, MD MPH Imperial County Public Health May 21, 2013 Objectives Assess the epidemiology of Coccidioidomycosis (aka Valley Fever) Describe the
Management of Multidrug- Resistant TB in Children. Jennifer Furin, MD., PhD. Sentinel Project, Director of Capacity Building
Management of Multidrug- Resistant TB in Children Jennifer Furin, MD., PhD. Sentinel Project, Director of Capacity Building Objectives To review data on best practices for diagnosis, treatment and prevention
GROUP A STREPTOCOCCUS (GAS) INVASIVE
GROUP A STREPTOCOCCUS (GAS) INVASIVE Case definition CONFIRMED CASE Laboratory confirmation of infection with or without clinical evidence of invasive disease: isolation of group A streptococcus (Streptococcus
Bacterial & Parasitic Infections in HIV
Bacterial & Parasitic Infections in HIV Aileen Y. Chang, MD Assistant Clinical Professor of Dermatology University of California, San Francisco Zuckerberg San Francisco General Hospital and Trauma Center
DIS News. Literature Highlight: Tofacitinib versus Placebo in Rheumatoid Arthritis. Inside this issue: October 2012
Colle ge of Health Professions and Biomedical Sciences Drug Information Service Literature Highlight: Tofacitinib versus Placebo in Rheumatoid Arthritis Biologic agents are reserved as second-line therapy